Order Article Reprints

Rojas-Bonilla M, Coulliette-Salmond A, Belgasmi H, Wong K, Sayyad L, Vega E, Grimoldi F, Oberste MS, Rüttimann R. Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama. Viruses. 2021; 13(7):1355. https://doi.org/10.3390/v13071355

Rojas-Bonilla, Magda, Angela Coulliette-Salmond, Hanen Belgasmi, Kimberly Wong, Leanna Sayyad, Everardo Vega, Fabian Grimoldi, M. Steven Oberste, and Ricardo Rüttimann. 2021. "Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama" Viruses 13, no. 7: 1355. https://doi.org/10.3390/v13071355

Rojas-Bonilla, M., Coulliette-Salmond, A., Belgasmi, H., Wong, K., Sayyad, L., Vega, E., Grimoldi, F., Oberste, M. S., & Rüttimann, R. (2021). Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama. Viruses, 13(7), 1355. https://doi.org/10.3390/v13071355